You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of Taenia Solium Specific Aptamers for Diagnostic Assays
SBC: LYNNTECH INC. Topic: ODCDCThe parasitic tapeworm Taenia solium causes two diseasestaeniasisadult worm in the intestineand cysticercosistissue infection by the cystwhich can lead to seizuresThe Tsolium life cycle involves both humans and pigshowever humans are the only definitive host for the adult Tsolium tapewormDiagnosing people infected with the adult worm is a critical step toward eliminating Tsolium althogetherHowever ...
SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Topic 379: Extensible and Scalable Platform for Data Integration from Wearable Sensors to Generate Novel Analytics for Cancer Patients
SBC: Litmus Health, Inc. Topic: NCIThe longterm objective of the Litmus Health platform is to allow researchers and clinicians to use data on cancer patients from wearables/sensors and smartphones. Collecting real-time, high-quality data from patients will transform care and clinical trials. Automating data collection, storage, analysis, and interpretation of data will result in better measurement of signs and symptoms and improved ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 372: Highly multiplexed selection of aptamers to hundreds of canine immunotherapy targets
SBC: BASE PAIR BIOTECHNOLOGIES INC Topic: NCIThe preclinical development of cancer therapeutics, including the recent trend and focus on cancer immunotherapies, is evolving from the traditional use of mouse models to the use of other animal models including canine, rat, and minipig. Each of these non-mouse models carries its own advantages and abilities to increase the clinical relevance of the model as compared to mouse models. Yet, the wid ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
In situ assay for RNA decapping in tumors
SBC: VIVID TECHNOLOGIES INC Topic: 102In situ assay for RNA decapping in tumors Abstract This project aims to introduce a new histotechnology to assess tumor cell stress and cell death propensitywhich can be useful in evaluating cancer response to therapyThe adaptive response of tumor cells to stress and their survival in hostile environments are signaled by the levels of mRNA decayIncreased decay dumps important mRNAs and marks cells ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Polyketide chiral building blocks and biocatalysts
SBC: Coala Biosciences Topic: 300PROJECT SUMMARY As with most synthetic chemistsCoALA Biosciences is inspired by naturally occurring polyketide assembly lineswhich synthesize diverse medicines through reactions that generate carbon carbon bonds and precisely set stereocentersIf chemists were to collaborate with the enzymes in these assembly linessyntheses of compounds in the drug discovery process would be greatly accelerated and ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Numeric Expansion of CD-19 Specific T cells in Magnetic 3D Culture
SBC: CHEMOSEN3D INC Topic: NIAIDProject Summary Adoptive immunotherapy trials using genetically modified natural killerNKand T cells with redirected specificity against B cell malignancies have demonstrated therapeutic efficacyTwo early phase clinical trials have been initiated at The University of Texas MDAnderson Cancer Center to evaluate the safety and efficacy of adoptive transfer of autologous and allogeneic T cells express ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Small molecule Inhibitors of steroid receptor coactivator to treat breast cancer
SBC: Coactigon, Inc. Topic: 102ABSTRACTSteroid Receptor CoactivatorSRCis a key breast cancer oncogene that is frequently overexpressed or amplified in estrogen receptorERand human epidermal growth factor receptorHERpositive breast cancersElevated expression of SRCalso has been associated with resistance to tamoxifen therapy and with poor disease outcome in HERpositive breast cancersNumerous studies have shown that experimental ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Next Generation All Solid State NASS Lithium Batteries for Implantable Devices
SBC: LYNNTECH INC. Topic: RPROJECT SUMMARY Implantable Cardioverter DefibrillatorsICDand Cardiac Resynchronization Therapy DevicesCRT Dare exclusively powered by non rechargeable lithium primary batteriesand will eventually need to be replaced because of energy depletioneven if all the other components last indefinitelyDevice replacement can result in infection and electrical lead failurewhich are probably the most serious ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Nucleobase aminosugars with reduced ototoxicity
SBC: NUBAD LLC Topic: YPROJECT SUMMARYAminoglycosides are one of the cheapest and well known antibiotics in clinical use for overyearsbut one of the major limitations in their use is their ototoxicityWe are developing fast and low cost methods to develop aminoglycosides with antiribosomal activities and reduced toxicityIn this projectwe will identify novel aminoglycoside antibacterialsthat show reduced ototoxicityComple ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents
SBC: AM BIOTECHNOLOGIES, LLC Topic: 400ABSTRACTReflecting a particular physiological statebiomarkers are very important for earlier diagnosis of diseasesrealizing personalized medicineas well as facilitating drug development and discoveryFor these reasonssignificant research efforts are currently being directed towards biomarker discovery and transitioning them into clinical useAM Biotech is developing a new discovery proteomics platfo ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health